First-Line Antihypertensive for ARB Allergy
For a patient with hypertension who is allergic to ARBs, initiate treatment with a thiazide or thiazide-like diuretic (such as chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 12.5-25 mg daily), an ACE inhibitor, or a long-acting dihydropyridine calcium channel blocker as first-line monotherapy.
Recommended First-Line Options (in order of preference)
1. Thiazide/Thiazide-Like Diuretics (Strongest Evidence)
- Chlorthalidone 12.5-25 mg daily is preferred over hydrochlorothiazide due to its longer half-life and superior cardiovascular outcome data 1, 2
- High-quality evidence demonstrates thiazides reduce:
- Caveat: Monitor for hypokalemia, hyponatremia, and uric acid elevation 2
2. ACE Inhibitors (Excellent Alternative)
- Appropriate for non-Black patients as first-line therapy 1, 4
- Examples: lisinopril 10-40 mg daily, enalapril 5-40 mg daily 2
- Moderate-to-high quality evidence shows ACE inhibitors reduce:
- Important: Do NOT use if patient has history of angioedema with ACE inhibitors 2
- Note: While ARB allergy doesn't automatically preclude ACE inhibitors, exercise caution as cross-reactivity for angioedema exists, though rare 5
3. Long-Acting Dihydropyridine Calcium Channel Blockers
- Examples: amlodipine 2.5-10 mg daily, felodipine 2.5-10 mg daily 2
- Low-to-moderate quality evidence shows CCBs reduce:
- Well-tolerated but associated with dose-related pedal edema (more common in women) 2
Algorithmic Approach Based on Patient Characteristics
For non-Black patients <60 years:
For patients ≥60 years or Black patients:
- Start with thiazide diuretic OR calcium channel blocker 1, 4
- ACE inhibitors are NOT recommended as first-line in Black patients 6, 7
For patients with specific comorbidities:
- Heart failure with reduced ejection fraction: ACE inhibitor + beta-blocker (thiazide as add-on) 5, 8
- Coronary artery disease: ACE inhibitor or beta-blocker 8
- Chronic kidney disease with proteinuria: ACE inhibitor 5
- Post-stroke: ACE inhibitor/diuretic combination preferred 5
What NOT to Use
Beta-blockers: NOT recommended as first-line for uncomplicated hypertension, especially in patients ≥60 years 8, 6, 7, 9
- Inferior stroke prevention compared to other first-line agents 9
- Only use if compelling indication (e.g., coronary disease, heart failure)
Alpha-blockers: NOT first-line for uncomplicated hypertension 8, 6, 7
Combination Therapy Considerations
If blood pressure remains uncontrolled on monotherapy or if initial BP is ≥20/10 mmHg above target, consider initial combination therapy 10, 11:
Preferred combinations (avoiding ARBs):
- Thiazide + ACE inhibitor 5, 6
- Thiazide + calcium channel blocker 1, 6
- Calcium channel blocker + ACE inhibitor 1, 6
Single-pill combinations improve adherence and should be used when available 10, 11.
Critical Pitfalls to Avoid
Do NOT combine ACE inhibitor with ARB - this combination is explicitly not recommended due to increased risk of hypotension, hyperkalemia, and worsening renal function without additional benefit 5, 8, 6
Avoid assuming ARB allergy means ACE inhibitor allergy - while angioedema can occur with both classes, they are distinct. If ARB allergy was angioedema, wait 6 weeks before cautiously considering an ACE inhibitor 2
Monitor electrolytes with thiazides - hypokalemia should be avoided and may require potassium supplementation or combination with ACE inhibitor 8, 6
Avoid short-acting nifedipine - only long-acting dihydropyridine CCBs should be used 8